Knight Therapeutics | GUD - Lucro Operacional

Preço das Ações
7.20
Mudança Diária
0.12 1.69%
Mensal
13.56%
Anual
18.23%
Q1 Previsão
6.93




Lucro Operacional Alterar Data
Acasti Pharma USD -2.53M 560K 2025-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Avita Medical AUD -10.41M 742K 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Cronos Group USD -7.06M 62.31M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Moderna USD -857M 597M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Organigram Holdings CAD -20.13M 7.92M 2025-12
Organon & Co USD 388M 62M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12